EP 164: Groundbreaking advances in MMR-deficient rectal cancer, liquid biopsies, and precision oncology with Dr. Luis Diaz
The Genetics Podcast
00:00
Advances in MMR-Deficient Rectal Cancer Treatment
This chapter explores groundbreaking advances in treating MMR-deficient rectal cancer through immunotherapy and checkpoint inhibitors. It examines the significant findings from clinical trials, which showed remarkable tumor regression in patients, and discusses the historical context of hereditary cancer research linking to concepts like Lynch syndrome. Additionally, it highlights the implications of these advancements on cancer prevention and the evolving understanding of polyp formation in at-risk individuals.
Transcript
Play full episode
